Available Programs

Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine

Join us for this dynamic, CME-certified symposium! In this event, an expert panel will discuss their evolving use of TKIs to treat glioblastoma, and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

The Society for Neuro-Oncology has reviewed and approved this symposium as appropriate for presentation as an Industry Supported Symposium. The symposium constitutes the content and views of the sponsor and is not part of the official SNO Annual Meeting program.

1 upcoming events, beginning 11/22/2019More Information

AML: Expert Guidance on Current Standards and New Directions in Patient Care

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of AML.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Approaches to Personalized Treatment for CLL: Expert Guidance on Sequencing Therapy and Novel Agents

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the personalized treatment of patients with CLL.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Advances in Hemophilia A: Expert Guidance and Practical Case Discussions

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of hemophilia.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Approaches To Achieve the Best Possible Outcomes in Myeloma

Join us for this live, CME-certified symposium featuring discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of multiple myeloma. You will get practical insights from experts as they discuss their personal approaches for myeloma care.

You will also have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

1 upcoming events, beginning 12/06/2019More Information

New Directions in Treating Peripheral T-Cell Lymphomas: Expert Guidance and Case Discussions

Join us for this dynamic, CME-certified symposium! Led by Steven M. Horwitz, MD, an expert panel will reveal how they approach current therapeutic decisions for their patients with PTCL and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

β-Thalassemia: Expert Insights on New Therapies for an Old Disease

Join us for this dynamic, CME-certified symposium! Led by Maria Domenica Cappellini, MD, an international panel will reveal how experts approach current therapeutic decisions for their patients with β-thalassemia and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance for Clinical Management

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the use of Bruton’s tyrosine kinase (BTK) inhibitors to treat mantle cell lymphoma, chronic lymphocytic leukemia, and other B-cell malignancies

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of myeloproliferative neoplasms.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going

Join us for this dynamic, CME-certified symposium! Led by Stephen J. Schuster, MD, an expert panel will reveal how they currently use CAR T-cells to treat leukemia, lymphoma, and myeloma, and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

2 upcoming events, beginning 12/06/2019More Information

Leveraging Evolving Data to Inform Treatment in HR-Positive, HER2-Negative Advanced Breast Cancer

Join us for this dynamic, CME/MOC-certified symposium on the optimal treatment of patients with HR-positive, HER2-negative advanced breast cancer, featuring review and discussion of key clinical data and patient case studies by a panel of renowned breast cancer experts as well as a look ahead at promising agents in the setting of endocrine therapy–pretreated disease that may soon change practice.

Sign up now! Registration is complimentary.

Held in conjunction with SABCS® 2019

2 upcoming events, beginning 12/11/2019More Information

Practical Application of Immuno-Oncology in Renal Cell Carcinoma

Expert discussion of current best practices for using immunotherapy in the treatment of patients with renal cell carcinoma.

Not an official event of the 2020 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

2 upcoming events, beginning 02/13/2020More Information

Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Join us for this interactive, CME/MOC-certified symposium featuring insights from medical oncology and pathology experts on the latest data informing optimal implementation of immunotherapy biomarkers into the management of patients with lung cancer.

There are no upcoming events, please check back soon.

Immunotherapy in Urothelial Bladder Cancer: Current Treatments and Emerging Research

Thank you for your interest in the “Immunotherapy in Urothelial Bladder Cancer: Current Treatments and Emerging Research” symposium!

Though pre-registration is now closed, we do welcome on-site registrations. Please come to the Gaylord National Resort & Convention Center, Riverview Ballroom B 4-5 and see our on-site registration staff. Remember to bring your SITC badge with you to expedite your registration. 

 

The Immunotherapy in Urothelial Bladder Cancer: Current Treatments and Emerging Research, content and views expressed therein are those of the Clinical Care Options, LLC and not of SITC.

There are no upcoming events, please check back soon.

Incorporating the Latest Therapeutic Strategies for HCC: Collaborating to Optimize Patient Outcomes

Expert discussion of current best practices for treating patients with hepatocellular carcinoma.

Presented for attendees of the 70th AASLD Annual Meeting.  This event is sponsored by Clinical Care Options and supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., Bristol-Myers Squibb, Eisai, Exelixis and Merck & Co., Inc.  This is not an official function of the American Association for the Study of Liver Diseases. 

There are no upcoming events, please check back soon.

Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

Join us for this interactive, multidisciplinary, CME/MOC-certified symposium featuring expert perspectives from a pulmonologist, a radiation oncologist, and a medical oncologist on the optimal integration of immune checkpoint inhibitors into the treatment of patients with stage III NSCLC.

This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.

Pre-registration is now closed. We welcome you to register on-site by coming to the Sheraton New Orleans, Grand Ballroom AB, located on the Fifth Floor. Remember to bring your CHEST badge to expedite your registration.

There are no upcoming events, please check back soon.

Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

Join us for this live, CME/MOC-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts. The symposium will cover recent advances in the use of immunotherapy to optimize outcomes in patients with stage III NSCLC.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges, content and views expressed therein are those of the Clinical Care Options, LLC and not of SITC.

Thank you for your interest in the “Increasing Survival in Stage III NSCLC” symposium! Though pre-registration is now closed, we do welcome on-site registrations. Please come to the Gaylord National Resort & Convention Center, Riverview Ballroom A3 and see our on-site registration staff. Remember to bring your SITC badge with you to expedite your registration. 

 

There are no upcoming events, please check back soon.

Optimizing the Clinical Application of CAR T-Cell Therapy: Best Practices for the Community Setting

Interact with peers while gaining expert insight on how to best use CAR T-cells in the treatment of lymphomas and leukemias in this interactive, case-based 1-hour live meeting. The latest clinical data will be highlighted, as well as expert treatment options from CCO’s online CAR T-cell toxicity management tool. After the meeting, download the associated slideset for use in your clinic.

Register Now!

2 upcoming events, beginning 11/11/2019More Information

Expert Guidance on the Expanding Role of Immunotherapy in HNSCC: A Live Workshop Series

Learn how to utilize immune checkpoint inhibitors for HNSCC treatment to improve outcomes for your patients with these expert-led 1-hour case-based workshops.

There are no upcoming events, please check back soon.